Previous Close | 115.60 |
Open | 113.62 |
Bid | 114.62 x 0 |
Ask | 115.60 x 0 |
Day's Range | 113.62 - 113.62 |
52 Week Range | 85.64 - 195.56 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
What kind of opportunities can an engineer find through their work? Plenty, at Illumina! One employee shares how she makes a difference. Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / April 18, 2024 / Inside a lab that ...
The Medical Genome Initiative presents a paper in an effort to expand patient access to sequencing Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / April 17, 2024 / A recent literature review, published in the Nature journalGenomic ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received approval of its divestment plan for GRAIL from the European Commission (EC).